Pro-Con Debate: Fibrinogen Concentrate or Cryoprecipitate for Treatment of Acquired Hypofibrinogenemia in Cardiac Surgical Patients
JournalAnesthesia and Analgesia
PublisherWolters Kluwer Health
MetadataShow full item record
AbstractCryoprecipitate has been the gold standard for treating acquired hypofibrinogenemia in cardiac surgery for nearly 50 years. More recently, fibrinogen concentrate has been used off-label in the United States and is the standard in European countries and Canada to treat the acquired hypofibrinogenemia during cardiac surgery. Fibrinogen concentrate has multiple potential advantages including rapid reconstitution, greater dose predictability, viral inactivation during processing, and reduced transfusion-related adverse events. However, because fibrinogen concentrate lacks the other components contained in the cryoprecipitate, it may not be the "ideal" product for replacing fibrinogen in all cardiac surgical patients, particularly those with longer cardiopulmonary bypass duration. In this Pro-Con commentary article, we discuss the advantages and disadvantages of using fibrinogen concentrate and cryoprecipitate to treat acquired hypofibrinogenemia in cardiac surgical patients.
Rights/TermsCopyright © 2021 International Anesthesia Research Society.
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/16096
- Fibrinogen Concentrate as an Alternative to Cryoprecipitate in a Postcardiopulmonary Transfusion Algorithm in Infants Undergoing Cardiac Surgery: A Prospective Randomized Controlled Trial.
- Authors: Downey LA, Andrews J, Hedlin H, Kamra K, McKenzie ED, Hanley FL, Williams GD, Guzzetta NA
- Issue date: 2020 Mar
- Comparison of cryoprecipitate with fibrinogen concentrate for acquired hypofibrinogenaemia.
- Authors: Theodoulou A, Berryman J, Nathwani A, Scully M
- Issue date: 2012 Apr
- Protocol for a phase III, non-inferiority, randomised comparison of a new fibrinogen concentrate versus cryoprecipitate for treating acquired hypofibrinogenaemia in bleeding cardiac surgical patients: the FIBRES trial.
- Authors: Karkouti K, Callum J, Rao V, Heddle N, Farkouh ME, Crowther MA, Scales DC
- Issue date: 2018 Apr 20
- [Whether fibrinogen concentrates are necessary in Russia?].
- Authors: Galstian GM, Berkovskiĭ AL, Zhuravlev VV, Polokhov DM, Savchenko VG
- Issue date: 2014 May-Jun
- [The cryoprecipitate: that old unknown].
- Authors: Blasi A, Beltran J, Pereira A, Puig L
- Issue date: 2015 Apr